Guidelines for radioiodinated MIBG scintigraphy in children

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 30, Issue 5, 2003, Pages

  Olivier, Pierre ^a   Colarinha, Paula ^b   Fettich, Jure ^c   Fischer, Sibylle ^d   Frökier, Jörgen ^e   Giammarile, Francesco ^f   Gordon, Isky ^g   Hahn, Klaus ^d   Kabasakal, Levent ^h   Mann, Mike ⁱ   Mitjavila, Mercedes ^j   Piepsz, Amy ^k   Porn, Ute ^d   Sixt, Rune ^l   Van Velzen, Jeannette ^m  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

^b INSTITUTO PORTUGUÊS DE ONCOLOGIA DE LISBOA FRANCISCO GENTIL   (Portugal)

^c UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^d UNIVERSITY OF MUNICH   (Germany)

^e AARHUS UNIVERSITY HOSPITAL   (Denmark)

^f CENTRE LÉON BÉRARD   (France)

^g GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^h ISTANBUL UNIVERSITY   (Turkey)

ⁱ Red Cross Hospital   (South Africa)

^j HOSPITAL UNIVERSITARIO DE GETAFE   (Spain)

^k SAINT PIERRE UNIVERSITY HOSPITAL   (Belgium)

^l QUEEN SILVIA CHILDREN'S HOSPITAL   (Sweden)

^m NONE

more..

Author keywords

99mTc MIBG scintigraphy; Acquisition; Children; Indications; Processing

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 125; (3 IODOBENZYL)GUANIDINE I 131; ADRENERGIC RECEPTOR BLOCKING AGENT; AMIODARONE; AMLODIPINE; AMLODIPINE BESYLATE; BRONCHODILATING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; ENALAPRIL MALEATE; FENOTEROL; LABETALOL; NICARDIPINE; NIFEDIPINE; SALBUTAMOL; TERBUTALINE; XYLOMETAZOLINE;

DIAGNOSTIC PROCEDURE; DRUG UPTAKE; HUMAN; NEUROBLASTOMA; NUCLEAR MEDICINE; ONCOLOGY; PATIENT; PEDIATRICS; PRACTICE GUIDELINE; RADIATION DOSE; RADIATION PROTECTION; REVIEW; SCINTIGRAPHY; THYROID GLAND;

EID: 12444301364     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-003-1138-9     Document Type: Review

References (30)

1. Giammarile F, Boneu A, Edeline V, Lumbroso J, Siles S, Wioland M. Guide de realisation de la scintigraphie à la métaiodobenzylguanidine (MIBG) en oncologie pédiatrique. Med Nucl 2000; 24:35-41.
2. Shapiro B, Copp JE, Sisson JC, Eyre PL, Wallis J, Beierwaltes WH. Iodine-131 metaiodobenzylguanidine for the locating of suspected pheochromocytoma: experience in 400 cases. J Nucl Med 1985; 26:576-585.
3. Sisson JC, Shulkin BL. Nuclear medicine imaging of pheochromocytoma and neuroblastoma. Q J Nucl Med 1999; 43:217-223.
4. Leung A, Shapiro B, Hattner R, Kim E, de Kraker J, Ghazzar N, Hartmann O, Hoefnagel CA, Jamadar DA, Kloos R, Lizotte P, Lumbroso J, Rufini V, Shulkin BL, Sisson JC, Thein A, Troncone L. Specificity of radioiodinated MIBG for neural crest tumors in childhood. J Nucl Med 1997; 38:1352-1357.
5. 131Imetaiodobenzylguanidine. Eur J Nucl Med 1991; 18:191198.
6. Shulkin BL, Shapiro B. Current concepts on the diagnostic use of MIBG in children. J Nucl Med 1998; 39:679-688.
7. 131I-iodobenzylguanidine. J Nucl Med 1980; 21:349-353.
8. Khafagi FA, Shapiro B, Gross MD. The adrenal gland. In: Maisey MN, Britton KE, Gilday DL, eds. Clinical nuclear medicine. London: Chapman & Hall; 1989:271-291.
9. Kinnier-Wilson LM, Draper GJ. Neuroblastoma, its natural history and prognosis: a study of 487 cases. Br Med J 1974; 3:301-307.
10. Young JL Jr, Ries LG, Silverberg E, Horm JW, Miller RW. Cancer incidence, survival, and mortality for children younger than age 15 years. Cancer 1986; 58 (2 Suppl):598-602.
11. 131I-MIBG-scintigraphy in childhood neuroblastoma: five years of clinical experience. Pediatr Radiol 1990; 20:157-159.
12. Gelfand MJ. Meta-iodobenzylguanidine in children. Semin Nucl Med 1993; 23:231-242.
13. Lumbroso JD, Guermazi F, Hartmann O, et al. Meta-iodobenzylguanidine (MIBG) scans in neuroblastoma: sensitivity and specificity, a review of 115 scans. Prog Clin Biol Res 1988; 271:689-705.
14. Parisi MT, Greene MK, Dykes TM, Moraldo TV, Sandler ED, Hattner RS. Efficacy of metaiodobenzylguanidine as a scintigraphic agent for the detection of neuroblastoma. Invest Radiol 1992; 27:768-773.
15. Moyes J, McCready VR, Fullbrook A. Neuroblastoma: MIBG in its diagnosis and management. Berlin Heidelberg New York: Springer, 1989.
16. Perel Y, Conway J, Kletzel M, Goldman J, Weiss S, Feyler A, Cohn SL. Clinical impact and prognostic value of metaiodobenzylguanidine imaging in children with metastatic neuroblastoma. J Pediatr Hematol Oncol 1999; 21:13-18.
17. 131I]MIBG as a first line treatment in advanced neuroblastoma. Q J Nucl Med 1995; 39 (4 Suppl 1): 61-64.
18. 131I-metaiodobenzylguanidine in neuroblastoma: a phase II study in 26 patients. "Societe Francaise d'Oncologie Pediatrique" and Nuclear Medicine Co-investigators. J Nucl Biol Med 1991; 35:220-223.
19. 131I-MIBG in combination with other agents. Eur J Cancer 1999; 35:1171-1173.
20. Gordon I, Peters AM, Gutman A, Morony S, Dicks-Mireaux C, Pritchard J. Skeletal assessment in neuroblastoma - the pitfalls of iodine23-MIBG scans. J Nucl Med 1990; 31:129-134.
21. Solanki KK, Bomanji J, Moyes J, Mather SJ, Trainer PJ, Britton KE. A pharmacological guide to medicines which interfere with the biodistribution of radiolabelled meta-iodobenzylguanidine (MIBG). Nucl Med Commun 1992; 13:513-521.
22. Piepsz A, Hahn K, Roca I, Ciofetta G, Toth G, Gordon I, Kolinska J, Gwidlet J. A radiopharmaceuticals schedule for imaging in paediatrics. Paediatric Task Group European Association Nuclear Medicine. Eur J Nucl Med 1990; 17:127-129.
23. Stabin MG, Gelfand MJ. Dosimetry of pediatric nuclear medicine procedures. Q J Nucl Med 1998; 42:93-112.
24. Pintelon H, Jonckheer MH, Piepsz A. Paediatric nuclear medicine procedures: routine sedation or management of anxiety? Nucl Med Commun 1994; 15:664-666.
25. Rufini V, Fisher GA, Shulkin BL, Sisson JC, Shapiro B. Iodine-123-MIBG imaging of neuroblastoma: utility of SPECT and delayed imaging. J Nucl Med 1996; 37:1464-1468.
26. 123I-MIBG scintigraphy in neuroblastoma: a comparison between planar and SPECT imaging. Q J Nucl Med 1995; 39 (4 Suppl 1):25-28.
27. Gelfand MJ, Elgazzar AH, Kriss VM, Masters PR, Golsch GJ. Iodine-123-MIBG SPECT versus planar imaging in children with neural crest tumors. J Nucl Med 1994; 35:1753-1757.
28. Nakajo M, Shapiro B, Copp J, Kalff V, Gross MD, Sisson JC, Beierwaltes WH. The normal and abnormal distribution of the adrenomedullary imaging agent m-[I-131]iodobenzylguanidine I-131 MIBG) in man: evaluation by scintigraphy. J Nucl Med 1983; 24:672-682.
29. Bonnin F, Lumbroso J, Tenenbaum F, Hartmann O, Parmentier C. Refining interpretation of MIBG scans in children. J Nucl Med 1994; 35:803-810.
30. 123I-iodobenzylguanidine uptake in children. Q J Nucl Med 1995; 39 (4 Suppl 1):17-20.